Literature DB >> 3005365

Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells.

S Adler, P J Baker, R J Johnson, R F Ochi, P Pritzl, W G Couser.   

Abstract

To explore possible mechanisms by which complement membrane attack complexes (MAC) that are deposited in the glomerular mesangium might be pathogenic, we stimulated rat glomerular mesangial cells grown in vitro with nascent MACs formed from the purified human complement components C5b6 and normal human serum and measured production of superoxide ion (O2-) and hydrogen peroxide (H2O2). Mesangial cells incubated with C5b6 + serum, which results in cell membrane interaction with the MAC, produce 0.9 +/- 0.15 nmol O2-/10(5) cells per 30 min, which was significantly greater than the amount produced by cells incubated with C5b6 alone, serum alone, or decayed MACs that can no longer interact with the cell membrane (0.3 +/- 0.2, 0.4 +/- 0.1, 0.3 +/- 0.2 nmol O2-/10(5) cells per 30 min, respectively; P less than 0.02). Production of O2- after stimulation with MACs increased during the first 20 min of incubation but then plateaued. Cells exposed to decayed MACs produced small amounts of O2-, which did not increase from 20 to 60 min. Production of H2O2 was also observed after stimulation with MACs, and continued to increase during 60 min of incubation (1.22 +/- 0.16 nmol H2O2/10(5) cells per 60 min), whereas H2O2 production could not be detected after exposure to decayed MACs. Cell viability was not adversely affected by exposure to nascent MACs as determined by trypan blue exclusion or chromium-51 release. These results demonstrate that glomerular mesangial cell membrane interaction with the MAC stimulates the production of the toxic oxygen metabolites O- and H2O2. Activation of the terminal complement pathway by mesangial immune deposits in vivo might lead to tissue injury by stimulation of local production of toxic oxygen-free radicals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005365      PMCID: PMC423461          DOI: 10.1172/JCI112372

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase.

Authors:  N R Matheson; P S Wong; J Travis
Journal:  Biochem Biophys Res Commun       Date:  1979-05-28       Impact factor: 3.575

2.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

3.  Inhibition of collagen gelation by action of the superoxide radical.

Authors:  R A Greenwald; W W Moy
Journal:  Arthritis Rheum       Date:  1979-03

4.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

5.  The C5b-6 complex: reaction with C7, C8, C9.

Authors:  E R Podack; G Biesecker; W P Kolb; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

6.  The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.

Authors:  E R Podack; W P Kolb; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes.

Authors:  H Carp; A Janoff
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

8.  H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors.

Authors:  R K Root; J Metcalf; N Oshino; B Chance
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

9.  Cell populations and membrane attack complex in glomeruli of patients with post-streptococcal glomerulonephritis: identification using monoclonal antibodies by indirect immunofluorescence.

Authors:  G Parra; J L Platt; R J Falk; B Rodriguez-Iturbe; A F Michael
Journal:  Clin Immunol Immunopathol       Date:  1984-12

10.  Free radicals and inflammation: protection of synovial fluid by superoxide dismutase.

Authors:  J M McCord
Journal:  Science       Date:  1974-08-09       Impact factor: 47.728

View more
  41 in total

1.  Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis.

Authors:  D H Lovett; R J Johnson; H P Marti; J Martin; M Davies; W G Couser
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species.

Authors:  N Kashihara; Y Watanabe; H Makino; E I Wallner; Y S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

3.  Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat.

Authors:  L C Paul; J Muralidharan; S A Muzaffar; E H Manting; J F Valentin; E de Heer; M Kashgarian
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

5.  Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.

Authors:  T S Halstensen; T E Mollnes; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

6.  Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae.

Authors:  F Tedesco; O Radillo; G Candussi; A Nazzaro; T E Mollnes; D Pecorari
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  Interleukin 1beta decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation.

Authors:  M H Zou; T Klein; J P Pasquet; V Ullrich
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

Review 8.  Complement and Transplantation: From New Mechanisms to Potential Biomarkers and Novel Treatment Strategies.

Authors:  Julian K Horwitz; Nicholas H Chun; Peter S Heeger
Journal:  Clin Lab Med       Date:  2018-12-20       Impact factor: 1.935

9.  The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis.

Authors:  C Hugo; C Hugo; R Pichler; K Gordon; R Schmidt; M Amieva; W G Couser; H Furthmayr; R J Johnson
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.

Authors:  R H Pichler; J A Bassuk; C Hugo; M J Reed; E Eng; K L Gordon; J Pippin; C E Alpers; W G Couser; E H Sage; R J Johnson
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.